Efficacy and Safety of Docetaxel Plus Oxaliplatin and Capecitabine in the First Line Treatment of Advanced Gastric Adenocarcinoma

Objective. To evaluate the efficacy and safety of docetaxel plus oxaliplatin and capecitabine (DOX) in the first line treatment of advanced gastric adenocarcinoma. Methods. A total of 37 patients were enrolled into this study, and they received DOX regimen (docetaxel 75 mg/m(2) and oxaliplatin 130 m...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ying, Ye, Zhengbao, Xi, Wenqi, Ma, Tao, Shi, Min, Yang, Liu, Zhu, Zhenggang, Zhang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787590/
https://www.ncbi.nlm.nih.gov/pubmed/24151630
http://dx.doi.org/10.1155/2013/971096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787590/
https://www.ncbi.nlm.nih.gov/pubmed/24151630
http://dx.doi.org/10.1155/2013/971096

Ejemplares similares